Rx Digi Health Platform Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 3.04 M
- Company Age 8 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -96.49%
- Profit Growth -397.27%
- Ebitda -128.39%
- Net Worth -112.97%
- Total Assets -99.24%
About Rx Digi Health Platform
Rx Digi Health Platform Private Limited (RDHPPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 May 2016 (Eight years and eight months 25 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Internet Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.04 M, as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999KA2016PTC093142
-
Company No.
093142
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 May 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Rx Digi Health Platform?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shyam Vasudevarao
|
Director | 12-May-2016 | Current |
|
Shailendra Nalige
|
Director | 12-May-2016 | Current |
Financial Performance of Rx Digi Health Platform.
Rx Digi Health Platform Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 96.49% decrease. The company also saw a substantial fall in profitability, with a 397.27% decrease in profit. The company's net worth observed a substantial decline by a decrease of 112.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rx Digi Health Platform?
In 2023, Rx Digi Health Platform had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Maastricht Education And Research Centre Private LimitedShyam Vasudevarao is a mutual person
-
Forus Health Private LimitedShyam Vasudevarao is a mutual person
-
Renalyx Health Systems Private LimitedShyam Vasudevarao is a mutual person
-
Automedix Private LimitedShyam Vasudevarao is a mutual person
-
Autoyos Private Limited
Shyam Vasudevarao is a mutual person
-
Ehe Innovations Private Limited
Shailendra Nalige is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rx Digi Health Platform?
Unlock and access historical data on people associated with Rx Digi Health Platform, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rx Digi Health Platform, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rx Digi Health Platform's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.